Accuracy of diagnostic codes to identify metastatic prostate cancer in medicare claims database
Authors:
- 5 March 2026
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 102, 103041
Abstract
No abstract availableKeywords
Funding Information
- Bayer HealthCare
This publication has 3 references indexed in Scilit:
- Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017MMWR. Morbidity and Mortality Weekly Report, 2020
- Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stageAnnals of Epidemiology, 2014
- Bone metastasis (BM) based on SEER registry versus Medicare claims among metastatic prostate cancer (PCa) patients (pts) in SEER-Medicare.Journal of Clinical Oncology, 2012